✦ LIBER ✦

PAR 13 COST-EFFECTIVENESS OFVALDECOXIB COMPARED TO DICLOFENAC IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN THE UK (UK) AND GERMANY

✍ Scribed by RH Alten; B von Scheele; L Gaffney; F Maciver; L Niculescu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PAO4: THE COST-EFFECTIVENESS OF CELECOXI

✍ E Orlewska 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PAR5 THE TOTAL COSTS OF TREATMENT WITH V

✍ B von Scheele; J DePlatchett; L Gaffney; BM Peña; L Niculescu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

PMS30 Cost-Effectiveness of Tocilizumab

✍ A. Diamantopoulos; S. Andrade; A. Bernardo; J. Branco; L. Inês; J.A. Pereira da 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PMS35 Cost-Effectiveness of Tocilizumab

✍ I. Ertenli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

CV3 COST-EFFECTIVENESSS OF INTENSIVE STA

✍ MF Drummond; JS Schwartz; M Koren; C Cannon; A Davie; A Shui; S Murphy; J Graff 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PIN64 Assessing the Cost-Effectiveness (

✍ Y. Jiang; A. Gauthier; S.T. Keeping; S.M. Carroll 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB